Table: Kyorin Pharmaceutical -2025/26 parent results

Kyorin Pharmaceutical

12/05/2026 07:33

May 12 (Reuters)- 
          Kyorin Pharmaceutical Co., Ltd. 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to     NEXT     
              Mar 31, 2026    Mar 31, 2025   Mar 31, 2027     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales          110.93          115.92         105.40        50.00    
               (-4.3 pct)      (+10.2 pct)    (-5.0 pct)    (-3.2 pct) 
  Operating        4.29           12.90           2.60       500 mln   
               (-66.8 pct)     (+87.2 pct)    (-39.3 pct)  (-75.6 pct) 
  Recurring        5.05           13.71           3.30       900 mln   
               (-63.2 pct)     (+79.6 pct)    (-34.6 pct)  (-63.1 pct) 
  Net              4.18            9.38           2.20       500 mln   
               (-55.4 pct)     (-82.3 pct)    (-47.4 pct)  (-76.3 pct) 
  EPS           72.82 yen      163.29 yen      38.29 yen     8.70 yen  
  Ann Div       57.00 yen       57.00 yen      25.00 yen               
  -Q2 Div       20.00 yen       20.00 yen      10.00 yen               
  -Q4 Div       37.00 yen       37.00 yen      15.00 yen               
  
  NOTE - Kyorin Pharmaceutical Co., Ltd.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4569.T